Definitive Contract HT940623C0007
Award Date
10/1/23
Potential Completion Date
4/1/29
Potential Value
$1M
Federal Agency
Defense Health Agency
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Portsmouth, VA 23708, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
The Defense Health Agency awarded a firm-fixed-price purchase order to Immucor Inc., a for-profit manufacturer of goods, for the delivery of blood typing reagents. The $228,353.45 contract has an ultimate completion date of September 30, 2027. Immucor has previously provided a variety of in vitro diagnostic products, reagents, test kits, and blood banking supplies to federal agencies such as the Department of Veterans Affairs and the Indian Health Service. This award is not set aside and is...
This is a federal contract award to Immucor Inc., a leading provider of automated in vitro diagnostics, reagents, and test kits for blood transfusion and transplantation compatibility testing. The contract, awarded by the Defense Health Agency, is for the delivery of blood bank reagents under a firm fixed-price, indefinite delivery contract with a ceiling value of $242,001.84 and a period of performance through September 30, 2027. The contract was awarded on September 18, 2024 and is not...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of automated blood testing equipment, reagents, and consumables. The contract, valued at $54,457.50, is for the provision of blood typing equipment and reagents. The contract does not have a set-aside designation. Immucor Inc. is a key supplier of specialized blood banking technologies and supplies that support medical testing and healthcare operations across federal...
This is a delivery order awarded to Immucor Inc. under the Defense Health Agency's federal contract vehicle. The $17,097.60 firm fixed price order is for the supply of blood bank reagents to support the agency's blood transfusion and immunohematology testing programs. The ultimate completion date for this order is September 30, 2025. Immucor is a leading manufacturer of automated in vitro diagnostic systems and consumables for blood typing and compatibility testing used in medical facilities,...
This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a leading provider of automated in vitro diagnostic solutions for blood banking and transplantation. The contract, valued at $114,014.55, is for the delivery of Immucor's specialized reagents to support blood typing, compatibility testing, and other critical blood banking operations within military treatment facilities and federal healthcare networks. The contract is a firm fixed-price...
This is a firm fixed-price delivery order contract awarded by the Air Education and Training Command, a defense agency, to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract is for the provision of blood typing reagents, with a ceiling value of $121,323.95 and a completion date of September 30, 2020. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare agencies, including the Department of Veterans...
This federal contract award is for the delivery of blood bank reagents to support the operations of the Defense Health Agency (DHA) from June 13, 2024 to September 30, 2024. The $35,616.26 firm fixed price delivery order was awarded to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products and blood banking supplies. Immucor has previously held multiple award schedule contracts and other federal awards with agencies such as the Department of Veterans Affairs and Indian Health...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products. The contract, valued at $403,914.14, is for the provision of specialized medical supplies such as blood bank analyzers, reagents, test kits, and related consumables. The contract is issued under the General Services Administration (GSA) Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests, and has an ultimate completion...